Pressure BioSciences Stock Price, News & Analysis (OTCMKTS:PBIO)

$4.00 0.00 (0.00 %)
(As of 12/17/2017 10:54 AM ET)
Previous Close$4.00
Today's Range$4.00 - $4.00
52-Week Range$0.70 - $11.52
Volume77 shs
Average Volume2,589 shs
Market Capitalization$4.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51

About Pressure BioSciences (OTCMKTS:PBIO)

Pressure BioSciences, Inc. is focused on solving the problems inherent in biological sample preparation. The Company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels, such as approximately 35,000 pounds per square inch (psi) or greater to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources. Its laboratory instrument, the Barocycler, and its consumables product line, which include its Pressure Used to Lyse Samples for Extraction (PULSE) tubes, and other processing tubes, and application specific kits, such as consumable products and reagents, together make up its PCT Sample Preparation System (PCT SPS). The Company is also the distributor for the Constant Systems cell disruption equipment, parts, and consumables.

Receive PBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for PBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:PBIO
CUSIPN/A
Phone508-230-1828

Debt

Debt-to-Equity RatioN/A
Current Ratio0.13%
Quick Ratio0.05%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$1.98 million
Price / Sales2.34
Cash FlowN/A
Price / CashN/A
Book Value($14.24) per share
Price / Book-0.28

Profitability

Trailing EPS($7.11)
Net Income$-2,700,000.00
Net Margins-245.53%
Return on EquityN/A
Return on Assets-623.52%

Miscellaneous

Employees13
Outstanding Shares1,160,000

Pressure BioSciences (OTCMKTS:PBIO) Frequently Asked Questions

What is Pressure BioSciences' stock symbol?

Pressure BioSciences trades on the OTCMKTS under the ticker symbol "PBIO."

How were Pressure BioSciences' earnings last quarter?

Pressure BioSciences Inc. (OTCMKTS:PBIO) announced its quarterly earnings results on Tuesday, May, 16th. The company reported ($0.18) earnings per share (EPS) for the quarter. The business earned $0.55 million during the quarter. View Pressure BioSciences' Earnings History.

When will Pressure BioSciences make its next earnings announcement?

Pressure BioSciences is scheduled to release their next quarterly earnings announcement on Wednesday, March, 28th 2018. View Earnings Estimates for Pressure BioSciences.

Who are some of Pressure BioSciences' key competitors?

Who are Pressure BioSciences' key executives?

Pressure BioSciences' management team includes the folowing people:

  • Jeffery N. Peterson, Independent Chairman of the Board (Age 62)
  • Richard T. Schumacher, President, Chief Executive Officer, Treasurer, Secretary, Clerk, Director (Age 67)
  • Joseph L. Damasio Jr., Chief Financial Officer, Vice President - Finance (Age 42)
  • Edmund Y. Ting Ph.D., Senior Vice President - Engineering
  • Nathan P. Lawrence Ph.D., Vice President of Sales and Marketing
  • Alexander V. Lazarev Ph.D., Vice President - Research & Development
  • Michael S. Urdea, Director (Age 65)
  • Vito J. Mangiardi, Independent Director (Age 68)
  • Kevin A. Pollack, Independent Director (Age 47)

How do I buy Pressure BioSciences stock?

Shares of Pressure BioSciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pressure BioSciences' stock price today?

One share of Pressure BioSciences stock can currently be purchased for approximately $4.00.

How big of a company is Pressure BioSciences?

Pressure BioSciences has a market capitalization of $4.62 million and generates $1.98 million in revenue each year. The company earns $-2,700,000.00 in net income (profit) each year or ($7.11) on an earnings per share basis. Pressure BioSciences employs 13 workers across the globe.

How can I contact Pressure BioSciences?

Pressure BioSciences' mailing address is 14 NORFOLK AVENUE, SOUTH EASTON MA, 02375. The company can be reached via phone at 508-230-1828 or via email at [email protected]


MarketBeat Community Rating for Pressure BioSciences (PBIO)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Pressure BioSciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pressure BioSciences (OTCMKTS:PBIO) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Pressure BioSciences (OTCMKTS:PBIO) Earnings History and Estimates Chart

Earnings by Quarter for Pressure BioSciences (OTCMKTS:PBIO)

Pressure BioSciences (OTCMKTS PBIO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/28/2018        
8/16/2017Q2 2017($0.90)($0.54)$0.78 million$0.54 millionViewN/AView Earnings Details
5/16/2017Q1 2017($0.18)$0.55 millionViewN/AView Earnings Details
8/17/2015($0.04)($0.09)$0.58 million$0.41 millionViewN/AView Earnings Details
4/1/2015($0.07)($0.09)$0.50 million$0.29 millionViewN/AView Earnings Details
11/17/2014($0.11)($0.07)$0.46 million$0.37 millionViewN/AView Earnings Details
8/14/2014($0.11)($0.05)$0.39 million$0.31 millionViewN/AView Earnings Details
5/15/2014($0.10)($0.25)$0.34 million$0.40 millionViewN/AView Earnings Details
4/2/2014($0.07)($0.14)ViewN/AView Earnings Details
8/15/2013Q2 2013($0.06)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Pressure BioSciences (OTCMKTS:PBIO) Earnings Estimates

Current Year EPS Consensus Estimate: $-8.41 EPS
Next Year EPS Consensus Estimate: $-1.18 EPS

Dividends

Dividend History for Pressure BioSciences (OTCMKTS:PBIO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Pressure BioSciences (OTCMKTS PBIO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 21.02%
Insider Trades by Quarter for Pressure BioSciences (OTCMKTS:PBIO)

Pressure BioSciences (OTCMKTS PBIO) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2014Richard T SchumacherCEOBuy13,200$0.30$3,960.00View SEC Filing  
9/13/2013Richard T SchumacherCEOBuy2,500$0.31$775.00View SEC Filing  
9/12/2013Richard T SchumacherCEOBuy20,500$0.30$6,150.00View SEC Filing  
9/9/2013Richard T SchumacherCEOBuy15,500$0.28$4,340.00View SEC Filing  
8/30/2013Michael S UrdeaDirectorBuy50,000$0.29$14,500.00View SEC Filing  
8/30/2013Richard T SchumacherCEOBuy10,000$0.29$2,900.00View SEC Filing  
8/28/2013Richard T SchumacherCEOBuy15,000$0.28$4,200.00View SEC Filing  
8/23/2013Richard T SchumacherCEOBuy20,000$0.27$5,400.00View SEC Filing  
8/21/2013Kevin PollackDirectorBuy10,000$0.28$2,800.00View SEC Filing  
10/8/2012Clayton A StruveMajor ShareholderBuy76,350$0.38$29,013.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Pressure BioSciences (OTCMKTS PBIO) News Headlines

Source:
DateHeadline
Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.
finance.yahoo.com - December 13 at 10:29 AM
Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:15 AM
PBIO: Revenue Expected to Continue to GrowPBIO: Revenue Expected to Continue to Grow
finance.yahoo.com - November 18 at 10:47 AM
Pressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business UpdatePressure BioSciences, Inc. Reports Third Quarter 2017 Financial Results and Provides Business Update
finance.yahoo.com - November 15 at 7:17 AM
Pressure BioSciences Inc. (PBIO) Issues Quarterly  Earnings Results, Misses Estimates By $1.17 EPSPressure BioSciences Inc. (PBIO) Issues Quarterly Earnings Results, Misses Estimates By $1.17 EPS
www.americanbankingnews.com - November 14 at 9:10 AM
Pressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business UpdatePressure BioSciences, Inc. to Discuss Third Quarter 2017 Financial Results and Provide Business Update
finance.yahoo.com - November 14 at 6:40 AM
Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into ChinaPressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China
finance.yahoo.com - November 2 at 7:32 AM
Pressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into ChinaPressure BioSciences Initiates Aggressive Marketing and Sales Strategy Expected to Drive Significant Expansion into China
finance.yahoo.com - November 2 at 7:32 AM
NetworkNewsWire Releases Exclusive Audio Interview with Pressure BioSciences Inc. (PBIO)NetworkNewsWire Releases Exclusive Audio Interview with Pressure BioSciences Inc. (PBIO)
finance.yahoo.com - October 27 at 9:26 AM
Pressure BioSciences, Inc. Discusses Market Opportunity, Differentiating Factors and New Patents in New SNNLive Video Interview with StockNewsNow.comPressure BioSciences, Inc. Discusses Market Opportunity, Differentiating Factors and New Patents in New SNNLive Video Interview with StockNewsNow.com
finance.yahoo.com - October 24 at 8:16 AM
Pressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble NanoemulsionsPressure BioSciences and Phasex Announce Strategic Collaboration Addressing Broad Markets for Stable, Water-Soluble Nanoemulsions
finance.yahoo.com - October 19 at 7:21 AM
CEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive UpturnCEO Richard T. Schumacher Discusses Pressure BioScience’s New Sales Team and Novel Products that are Fueling its Progressive Upturn
finance.yahoo.com - October 11 at 6:24 AM
Pressure BioSciences Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and IrelandPressure BioSciences' Penetration in European Biopharma and High Pressure Markets Continuing to Expand via Multiple Scientific Presentations in Germany, Poland, and Ireland
finance.yahoo.com - October 11 at 6:24 AM
Pressure BioSciences, Inc. to Present at the 2017 Disruptive Growth Company Showcase in New York City on September 27, 2017Pressure BioSciences, Inc. to Present at the 2017 Disruptive Growth Company Showcase in New York City on September 27, 2017
finance.yahoo.com - October 3 at 3:16 AM
Pressure BioSciences, Inc. Issued First Two Patents on Widely-Applicable, High Pressure-Based Ultra Shear Technology ("UST")Pressure BioSciences, Inc. Issued First Two Patents on Widely-Applicable, High Pressure-Based Ultra Shear Technology ("UST")
finance.yahoo.com - October 3 at 3:16 AM
Pressure BioSciences Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 AwardsPressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards
finance.yahoo.com - September 19 at 6:20 AM
Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017Pressure BioSciences, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on September 11, 2017
finance.yahoo.com - September 12 at 8:26 AM
Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Pressure BioSciences, Inc. :PBIO-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 8:11 AM
Pressure BioSciences Inc. (PBIO) Releases Quarterly  Earnings Results, Beats Estimates By $0.33 EPSPressure BioSciences Inc. (PBIO) Releases Quarterly Earnings Results, Beats Estimates By $0.33 EPS
www.americanbankingnews.com - August 16 at 10:50 AM
Pressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business UpdatePressure BioSciences, Inc. to Discuss Second Quarter 2017 Financial Results and Provide Business Update
finance.yahoo.com - August 16 at 6:38 AM
PRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual ReportPRESSURE BIOSCIENCES INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 22 at 7:07 PM
FinancialBuzz.com Innovation in the Sample Preparation MarketFinancialBuzz.com Innovation in the Sample Preparation Market
www.bizjournals.com - March 1 at 10:17 AM
PRESSURE BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersPRESSURE BIOSCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - January 3 at 11:45 PM
Q3 2016 Pressure Biosciences Inc Earnings Release - Time Not SuppliedQ3 2016 Pressure Biosciences Inc Earnings Release - Time Not Supplied
biz.yahoo.com - November 16 at 10:27 AM

SEC Filings

Pressure BioSciences (OTCMKTS:PBIO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Pressure BioSciences (OTCMKTS:PBIO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Pressure BioSciences (OTCMKTS PBIO) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.